What is PolyPid?
, a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 132.25M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.